ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs1.13 B1.04 B1.03 B1.04 B1.11 B1.12 B4.3 BRecherche et développement344 M344 M302 M292 M322 M345 M1.26 BRésultat d'exploitation801 M629 M654 M653 M827 M515 M2.65 BTotal des produits hors exploitation169 M264 M77 M117 M140 M78 M412 MCharges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts116 M165 M78 M91 M107 M42 M318 MRevenus/dépenses exceptionnels53 M99 M-1 M26 M33 M36 M94 MRésultat avant impôts833 M692 M613 M643 M820 M505 M2.58 BPart des actionnaires dans le résultat3 M3 M1 M0-1 M-3 M-3 MImpôts96 M104 M113 M179 M218 M94 M604 MIntérêts ne donnant pas le contrôle / intérêts minoritaires17 M24 M14 M18 M14 M22 M68 MAutres produits/charges après impôts———————Résultat net avant activités abandonnées721 M564 M486 M446 M588 M389 M1.91 BActivités abandonnées0———0——Résultat net721 M564 M486 M446 M588 M389 M1.91 BAjustement de dilution0——————Dividendes privilégiés0——————Résultat net dilué revenant aux actionnaires ordinaires721 M564 M486 M446 M588 M389 M1.91 BBénéfice par action de base (BPA de base)1.581.231.060.981.290.854.18Bénéfice par action dilué (BPA dilué)1.581.231.060.981.280.854.17Nombre moyen d'actions de base en circulation456 M457 M457 M456 M456 M456 M—Nombre d'actions en circulation après dilution459 M459 M458 M457 M458 M457 M—EBITDA4.22 B3.53 B3.82 B3.96 B4.63 B3.82 B16.23 BEBIT3.85 B3.39 B3.68 B3.81 B4.26 B3.67 B15.41 BCoût des ventes———————Autres coûts des ventes———————Amortissements (flux de trésorerie)377 M136 M147 M149 M365 M153 M814 M
GE HealthCare Technologies Inc. - Common Stock
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India.